» Articles » PMID: 22160907

Recombinant Protein Production in Yeasts

Overview
Specialty Molecular Biology
Date 2011 Dec 14
PMID 22160907
Citations 109
Authors
Affiliations
Soon will be listed here.
Abstract

Recombinant protein production is a multibillion-dollar market. The development of a new product begins with the choice of a production host. While one single perfect host for every protein does not exist, several expression systems ranging from bacterial hosts to mammalian cells have been established. Among them, yeast cell factories combine the advantages of being single cells, such as fast growth and easy genetic manipulation, as well as eukaryotic features including a secretory pathway leading to correct protein processing and post-translational modifications. In this respect, especially the engineering of yeast glycosylation to produce glycoproteins of human-like glycan structures is of great interest. Additionally, different attempts of cellular engineering as well as the design of different production processes that are leading to improved productivities are presented. With the advent of cheaper next-generation sequencing techniques, systems biotechnology approaches focusing on genome scale analyses will advance and accelerate yeast cell factories and thus recombinant protein production processes in the near future. In this review we summarize advantages and limitations of the main and most promising yeast hosts, including Saccharomyces cerevisiae, Pichia pastoris, and Hansenula polymorpha as those presently used in large scale production of heterologous proteins.

Citing Articles

Strangers in a foreign land: 'Yeastizing' plant enzymes.

Van Gelder K, Lindner S, Hanson A, Zhou J Microb Biotechnol. 2024; 17(9):e14525.

PMID: 39222378 PMC: 11368087. DOI: 10.1111/1751-7915.14525.


Allergen Microarrays and New Physical Approaches to More Sensitive and Specific Detection of Allergen-Specific Antibodies.

Sokolov P, Evsegneeva I, Karaulov A, Sukhanova A, Nabiev I Biosensors (Basel). 2024; 14(7).

PMID: 39056629 PMC: 11275078. DOI: 10.3390/bios14070353.


Antimicrobial Peptides towards Clinical Application-A Long History to Be Concluded.

Cresti L, Cappello G, Pini A Int J Mol Sci. 2024; 25(9).

PMID: 38732089 PMC: 11084544. DOI: 10.3390/ijms25094870.


An impact of N-glycosylation on biochemical properties of a recombinant α-amylase from .

Kiribayeva A, Silayev D, Akishev Z, Baltin K, Aktayeva S, Ramankulov Y Heliyon. 2024; 10(6):e28064.

PMID: 38515717 PMC: 10956057. DOI: 10.1016/j.heliyon.2024.e28064.


Therapeutic proteins: developments, progress, challenges, and future perspectives.

Kumar V, Barwal A, Sharma N, Mir D, Kumar P, Kumar V 3 Biotech. 2024; 14(4):112.

PMID: 38510462 PMC: 10948735. DOI: 10.1007/s13205-024-03958-z.